Finance

Lists
Q2 2027 earnings • released • EPS beat +4.58% • Revenue beat +3.65%
See results
HAE:NYSE
Haemonetics Corp
$124.11
-2.60%
(-3.31) 1D
$124.11
0.00% (0.00)
After hours
Closed: Nov 5, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HAE...
Open
$126.06
High
$132.00
Low
$121.22
Mkt. cap
5.65B
Avg. vol.
695.00K
Volume
0.00
P/E ratio
60.54
52-wk high
$132.00
52-wk low
$51.00
EPS
$2.05
Beta
0.63
Shares outstanding
45.50M
No. of employees
3K
Open
$126.06
High
$132.00
Low
$121.22
Mkt. cap
5.65B
Avg. vol.
695.00K
Volume
0.00
P/E ratio
60.54
52-wk high
$132.00
52-wk low
$51.00
EPS
$2.05
Beta
0.63
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryMedical device
Websitehaemonetics.com
Analyst ratings
Based on 9 analysts giving stock ratings to HAE in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HAE in the last 3 months.
Highest
Current $124.11
$140.00 (+12.80%)
Average
$125.38 (+1.02%)
Lowest
$86.00 (-30.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
$140.00
+12.8%
10/26/2026
Michael Matson
Needham
Hold
Maintained
-
-
10/21/2026
Marie Thibault
BTIG
Buy
Maintained
$130.00
+4.7%
10/19/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$140.00
+12.8%
10/09/2026
Travis Steed
Bank of America Securities
Buy
Reiterated
$140.00
+12.8%
10/08/2026
Joanne Wuensch
Citi
Buy
Upgraded
$123.00
-0.9%
09/18/2026
Andrew Cooper
Raymond James
Buy
Maintained
$125.00
+0.7%
09/03/2026
David Rescott
Robert W. Baird
Buy
Maintained
$119.00
-4.1%
08/21/2026
Allen Gong
J.P. Morgan
Hold
Maintained
$86.00
-30.7%
08/10/2026
Rohin K Patel
J.P. Morgan
Hold
Reiterated
$62.00
-50%
05/08/2026
Last report
Nov 5, 2026
Fiscal period
Q2 2027
$1.35 / $1.29
+4.58%beat
Revenue / Est. (USD)
357.76M / 345.15M
+3.65%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
327.32M
338.97M
346.35M
339.38M
Cost of goods sold
132.71M
136.63M
148.10M
135.79M
Cost of revenue
132.71M
136.63M
148.10M
135.79M
Research and development expenses
14.52M
14.29M
14.41M
16.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.10M
105.90M
125.29M
116.32M
Operating expense
125.80M
131.12M
150.19M
142.73M
Total operating expenses
258.52M
267.75M
298.28M
278.52M
Operating income
68.80M
71.22M
48.07M
60.86M
Other non operating income
-7.21M
2.28M
-21.16M
2.22M
EBT including unusual items
51.28M
59.98M
-28.40M
47.57M
EBT excluding unusual items
61.59M
63.79M
37.79M
50.97M
Income tax expense
12.60M
15.24M
-8.25M
14.56M
Effective tax rate
24.57%
25.40%
29.06%
30.61%
Other operating expenses
-
-
-
-
Net income
38.68M
44.74M
-20.15M
33.01M
Net profit margin
11.82%
13.20%
-5.82%
9.73%
Earnings per share
1.27
1.31
1.29
1.14
Interest and investment income
-
-
10.10M
-
Interest expense
-
-9.70M
-
-12.40M
Net interest expenses
-
-9.70M
10.10M
-12.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
97.05M
98.60M
69.28M
87.97M
Gain or loss from assets sale
-75.00K
-218.00K
-178.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps